Bering Capital
VC · San Francisco · United States
Stages
Investment region
Industries
Profile
Bering Capital is a venture capital firm based in San Francisco, California, founded in 2020 by Evgeny Zaytsev and Philip Sawyer. The firm focuses on investing in innovative biotech and medical technology companies. With a team of five professionals, including two partners, Bering Capital is committed to supporting the growth of cutting-edge healthcare solutions. The firm primarily invests in life sciences, healthtech, and enterprise applications, targeting Series C and Series D rounds. Bering Capital's investments are concentrated in the United States, and the firm manages Bering Capital Fund I with an AUM of $50 million, launched in 2021. The firm is a Registered Investment Adviser (RIA) and actively seeks new investment opportunities. Notable portfolio companies include Coherus Biosciences - biopharmaceuticals, Atea Pharmaceuticals - antiviral therapeutics, CalciMedica - drug discovery, Dragon Vascular - vascular solutions, and Life Detection Technologies - monitoring equipment.
Contatos (2)
| Name | Title | Telefone | ||
|---|---|---|---|---|
| Venture capital investor | — | — | — | |
| Managing Partner | — | — | — |
Name, email and phone are partially hidden. Subscribe to see them in full.